Interleukin-2 enhances susceptibility of colon cancer cells to FasR-mediated apoptosis by up-regulating Fas receptor level and down-regulating FAP-1 expression

International Journal of Immunopathology and Pharmacology

Volumn 13, Issue 3, 2000, Pages 113-122

  Song, E ^a   Chen, J ^a   Antus, B ^a   Wang, M ^a   Xie, Y ^a   Ouyang, N ^a   Yao, H ^a   Exton, M S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Apoptosis; Colon neoplasms; Fas receptor; Fas associated phosphatase 1; Interleukin 2

Indexed keywords

FAS ANTIBODY; FAS ASSOCIATED PHOSPHATASE 1; FAS RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CH 11; PHOSPHATASE; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034533639     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
2. The CTL's kiss of death
3. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis
4. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
5. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium
6. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues
7. Effect of interleukin 2 on the proliferation of the intestinal cell lines and on the expression of TGF-beta gene and JUN/FOS oncogenes
8. Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines
9. The role of cytokines in cancer
10. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: Increased cytoxicity of MDR relevant drugs
11. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells
12. Modulation of mdr-1 expression by cytokines in human colon carcinoma cells: An approach for reversal of multidrug resistance
13. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells
14. Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95) Fas ligand on peripheral lymphocytes (a pilot study)
15. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines
16. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
17. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
18. Immunoregulation by cytokines
19. Modulation of TNF production in a rat mast cell line (RBL) and monocytes (THP-1) by cAMP and glucocorticoids
20. Tumor necrosis factor activity and cancer therapy - A perspective
21. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas
22. Apoptosis study in thymic involusion in tumor-bearing mice
23. CD95 (APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells
24. The Fas signaling pathway is functional in colon carcinoma cells and induces apoptosis
25. Interleukin-12, a new anti-tumor cytokine
26. FAP-1: A protein tyrosine phosphatase that associates with Fas
27. The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif
28. The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line